Intracranial broad-based aneurysms located at bifurcations remain a challenge for endovascular treatment. The WEB device (Sequent Medical, Aliso Viejo, California) was initially designed to address this kind of aneurysm. It allows placing within the sac of the aneurysm an intrasaccular device that will divert the flow towards the parent vessel.
From the very beginning, we have decided to carefully and prospectively assess the safety of the WEB device and its efficacy. For that purpose, we set up a registry named “the French Observatory”, which is a prospective observational study of consecutive cases with independent monitoring across 10 centers in France. Patients were enrolled from November 2012 to January 2014.
During the time-window of the registry, the WEB device has evolved from a dual-layer version (WEB-DL; CE-marked 2010) to a single-layer version (WEB-SL; CE-marked 2013). The latter was designed to offer smaller-sized devices with a lower profile in order to optimize navigability and delivery, which may in turn broaden its range of use.
Thus, we were naturally pushed to assess the potential advantage of the new WEB-SL compared with the WEB-DL in terms of safety and efficacy, and this is the topic that was addressed in this paper.
In our reported series, among 63 patients treated with the WEB, 31 were treated with WEB-DL and 32 with WEB-SL. We found that morbidity was similar in both groups (WEB-DL, 3.3%; WEB-SL, 3.1%), and mortality was 0.0% in both groups. However, the percentage of anterior communicating artery aneurysms treated with WEB-SL was significantly higher (37.5%) compared with WEB-DL (12.9%) (P = .04). The WEB-SL was more frequently used in aneurysms smaller than 10 mm compared with the WEB-DL (respectively, 96.9% and 67.7%; P = .002).